Plenary
Session IV
8:30 a.m. – 9:30 a.m.
|
| |
Keynote
Speaker: Leroy
Hood, MD PhD |
Break
9:30 a.m. – 10:00 a.m. |
Concurrent
Scientific Symposia
10:00 a.m. – 12:00 p.m. |
| |
Symposium
9: Genetic Diseases III: Blood Disorders
Chair:
Claudio Bordignon
Speakers:
|
| |
|
Katherine High
– AAV-mediated gene transfer for hemophilia
Alain Fischer – Gene therapy of severe combined immunodeficiencies
Michel Sadelain – Successful treatment of thalassemiaby globin gene
transfer
Harry Malek – Gene therapy for immune deficiencies: novel vectors
and approaches
|
| |
| |
Symposium
10: Neural Disorders II
Chair:
Xandra
Breakefield
Speakers:
|
| |
|
Beverly
Davidson – Approaching gene therapy for neurodegenerative diseases
Jean Bennett – Title to be announced
Jean Michael Heard – Gene therapy for axonal regrowth after nerve
autograft bridging in rat spinal cord injury model
Andrea Amalfitano – Efficacy of improved Adenovirus vectors for
the genetic therapy of the myopathic lysosomal storage disorder "Pompe
disease"
|
| |
| |
Symposium
11: Emerging Technologies
Chair:
Jim
Wilson
Speakers:
|
| |
|
Dieter
Gruenert – Technologies directed for site specific modifications of
genomic DNA
David Curiel – Advanced generation adenoviral vectors for
enhanced gene therapy
Hunt Willard – Title to be announced
Alan Colman – Title to be announced |
| |
| |
|
